Mary Wilson
Well-known member
Published Tuesday, September 22, 2020 10:32AM EDTLast Updated Tuesday, September 22, 2020 6:10PM EDT
Sarah Turnbull CTVNews.ca Producer
OTTAWA -- The federal government has inked a new deal with French multinational pharmaceutical firm Sanofi to obtain 72 million doses of its protein-based COVID-19 vaccine candidate.
Procurement Minister Anita Anand also said Tuesday that Canada is in line to secure up to 150,000 vials of Gilead Sciences and McKeeson Canada’s antiviral drug remdesivir, to treat the virus.
To date, Canada has allocated $1 billion to vaccine procurement, which translates to a minimum of 154 million doses of a future vaccine. Deals have already been signed with Pfizer, Moderna, Johnson & Johnson, and Novavax.
https://www.ctvnews.ca/politics/can...tent&utm_medium=trueAnthem&utm_source=twitter
Sarah Turnbull CTVNews.ca Producer
OTTAWA -- The federal government has inked a new deal with French multinational pharmaceutical firm Sanofi to obtain 72 million doses of its protein-based COVID-19 vaccine candidate.
Procurement Minister Anita Anand also said Tuesday that Canada is in line to secure up to 150,000 vials of Gilead Sciences and McKeeson Canada’s antiviral drug remdesivir, to treat the virus.
To date, Canada has allocated $1 billion to vaccine procurement, which translates to a minimum of 154 million doses of a future vaccine. Deals have already been signed with Pfizer, Moderna, Johnson & Johnson, and Novavax.
https://www.ctvnews.ca/politics/can...tent&utm_medium=trueAnthem&utm_source=twitter